Massachusetts Financial Services’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-68,201
Closed -$1.69M 849
2022
Q1
$1.69M Sell
68,201
-13,003
-16% -$394K ﹤0.01% 767
2021
Q4
$2.82M Sell
81,204
-14,991
-16% -$475K ﹤0.01% 739
2021
Q3
$2.61M Sell
96,195
-1,262
-1% -$32K ﹤0.01% 755
2021
Q2
$2.53M Buy
97,457
+63,124
+184% +$1.51M ﹤0.01% 756
2021
Q1
$740K Sell
34,333
-4,067
-11% -$103K ﹤0.01% 861
2020
Q4
$826K Sell
38,400
-384
-1% -$9.32K ﹤0.01% 808
2020
Q3
$572K Buy
+38,784
New +$700K ﹤0.01% 821

Other funds holding ANAB

Massachusetts Financial Services's ANAB Position: Q2 2022 in Review

Massachusetts Financial Services sold out of AnaptysBio (ANAB) in Q2 2022, closing a stake of 68,201 shares — an estimated $1.69M sold.

Massachusetts Financial Services first reported a position in ANAB in Q3 2020 and held it in 7 quarters. The position peaked at $2.82M in Q4 2021. 124 funds tracked by Wall St. Rank hold ANAB as of Q2 2022.

  • Massachusetts Financial Services reported no remaining AnaptysBio position as of Q2 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 68,201 AnaptysBio shares in Q2 2022, an estimated $1.69M.
  • Massachusetts Financial Services first reported a position in AnaptysBio in Q3 2020 and held it in 7 quarters.
  • Massachusetts Financial Services's AnaptysBio position peaked at $2.82M in Q4 2021.
  • 124 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2022.

Based on Massachusetts Financial Services's 13F filing for Q2 2022, filed 9 Aug 2022.